Prosecution Insights
Last updated: August 16, 2026

New England Biolabs Inc.

10 pending office actions • 10 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days

Portfolio Summary

10
Total Pending OAs
7
Non-Final OAs
2
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
1
Due this week
0
Due this month
1
Due in next 60 days
2
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Due ≤ 7 days (1)Due ≤ 60 days (1)Due later (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (70%)
2
Medium (20%)
1
Easy (10%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (20%)
§103 only2 (20%)
§112 only1 (10%)
Multi-statute (no §101)5 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

10
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RILEY, JEZIA 1 82.9% +7.3%
PAK, YONG D 1 74.6% +14.3%
YU, DAVID TUYANG 1 100.0% +0.0%
GIAMMONA, FRANCESCA FILIPPA 1 37.0% +55.9%
ROBINSON, HOPE A 1 67.6% +43.3%
HANDY, DWAYNE K 1 62.7% +24.9%
BUCHANAN, BAILEY CHEYENNE 1 47.6% +50.0%
SU-TOBON, QIWEN NMN 1 75.0% +100.0%
RAYMONDA, MATTHEW HAROLD 1 35.7% +55.0%
YAMASAKI, ROBERT J 1 67.4% +43.3%

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
17637430 Cleavage of Single Stranded DNA Having a Modified Nucleotide RAYMONDA, MATTHEW HAROLD 54d
17610081 Chemical Capping for Template Switching YAMASAKI, ROBERT J 70d
18706431 Compositions and Methods for Detecting Pyrophosphate Products of Enzyme Reactions Using Pyridylazoaniline Dyes RILEY, JEZIA
18390303 DUPLEX-SPECIFIC DNASES PAK, YONG D
18563125 Target Initiation and Amplification of Long DNA with Nuclease and Replisome Enzymes YU, DAVID TUYANG
18058115 Double-Stranded DNA Deaminases BUCHANAN, BAILEY CHEYENNE
17932136 Methods for Labeling a Population of RNA Molecules SU-TOBON, QIWEN NMN

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18155975 Isolation of High Molecular Weight DNA Using Beads HANDY, DWAYNE K 6d
17637430 Cleavage of Single Stranded DNA Having a Modified Nucleotide RAYMONDA, MATTHEW HAROLD 54d
17610081 Chemical Capping for Template Switching YAMASAKI, ROBERT J 70d
18452104 Rapid Diagnostic Test for LAMP GIAMMONA, FRANCESCA FILIPPA 71d
18390303 DUPLEX-SPECIFIC DNASES PAK, YONG D
18182122 IMMOBILIZED ENZYME COMPOSITIONS AND METHODS ROBINSON, HOPE A
18058115 Double-Stranded DNA Deaminases BUCHANAN, BAILEY CHEYENNE
17932136 Methods for Labeling a Population of RNA Molecules SU-TOBON, QIWEN NMN

Top Art Units

Art UnitApps
1681 1
1652 1
1651 1
1671 1
1637 1
1798 1
1682 1
1636 1
1684 1
1657 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18706431 Compositions and Methods for Detecting Pyrophosphate Products of Enzyme Reactions Using Pyridylazoaniline Dyes RILEY, JEZIA 1681 §101§102§103Other Non-Final OA Pending May 01, 2024
18390303 DUPLEX-SPECIFIC DNASES PAK, YONG D 1652 §101§102 Non-Final OA Pending Dec 20, 2023
18563125 Target Initiation and Amplification of Long DNA with Nuclease and Replisome Enzymes YU, DAVID TUYANG 1651 §102§103 Non-Final OA Pending Nov 21, 2023
18452104 Rapid Diagnostic Test for LAMP GIAMMONA, FRANCESCA FILIPPA 1671 §103 Non-Final OA 71d Pending Aug 18, 2023
18182122 IMMOBILIZED ENZYME COMPOSITIONS AND METHODS ROBINSON, HOPE A 1637 §112 Non-Final OA Pending Mar 10, 2023
18155975 Isolation of High Molecular Weight DNA Using Beads HANDY, DWAYNE K 1798 §103 Final Rejection 6d Pending Jan 18, 2023
18058115 Double-Stranded DNA Deaminases BUCHANAN, BAILEY CHEYENNE 1682 §102§103§112Other Final Rejection Pending Nov 22, 2022
17932136 Methods for Labeling a Population of RNA Molecules SU-TOBON, QIWEN NMN 1636 §103§112Other Non-Final OA Pending Sep 14, 2022
17637430 Cleavage of Single Stranded DNA Having a Modified Nucleotide RAYMONDA, MATTHEW HAROLD 1684 §103§112 Non-Final OA 54d Pending Feb 22, 2022
17610081 Chemical Capping for Template Switching YAMASAKI, ROBERT J 1657 §103§112 Non-Final OA 70d Pending Nov 09, 2021

Managing New England Biolabs Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month